Illumina（ILMN）在CMS精准肿瘤学报销里程碑后的估值审视 - simplywall.st
Illumina (ILMN) Valuation Check After CMS Reimbursement Milestone In Precision Oncology - simplywall.st
生命科学资讯
生物技术与制药领域的最新动态
贝利·吉福德公司减持Illumina, Inc.股份 $ILMN - 市场脉搏
Baillie Gifford & Co. Lowers Stake in Illumina, Inc. $ILMN - MarketBeat
德州教师退休系统减持Illumina公司（股票代码ILMN）股份 - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Teacher Retirement System of Texas - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH购入40,166股Illumina, Inc. $ILMN股票 - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Purchases 40,166 Shares of Illumina, Inc. $ILMN - MarketBeat
2031年全基因组测序市场展望：市场规模达45亿美元，重点介绍Illumina、Thermo Fisher Scientific、Oxford Nanopore Technologies等领先企业 - 雅虎财经新加坡版
$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players - Yahoo Finance Singapore
Illumina股价上涨5.9%：CMS支持TruSight Oncology全面报销方案
Why Illumina (ILMN) Is Up 5.9% After CMS Backs TruSight Oncology Comprehensive Reimbursement - simplywall.st
前Illumina高管转任Quanterix首席执行官 - 医疗产品外包
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
迪拜卫生部门采用基因组学推动医疗与科研发展——Illumina
Dubai Health embraces genomics to advance care and research - Illumina
Illumina (NASDAQ:ILMN) 创下52周新高——市场动态解析
Illumina (NASDAQ:ILMN) Sets New 52-Week High - Here's What Happened - MarketBeat
Illumina与Powell Gilbert律师事务所钟情里斯本——JUVE专利
Illumina and Powell Gilbert in love with Lisbon - JUVE Patent
客户互动中心 - Illumina
Customer Engagement Center - Illumina
利用Oragene™采集设备优化唾液DNA的Illumina长读长全基因组测序
Optimizing Illumina Long-Read Whole Genome Sequencing of Salivary DNA Using Oragene™ Collection Devices - the-scientist.com
Illumina获FDA批准的TruSight Oncology综合测试获报销，股价下跌 - 纳斯达克
Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down - Nasdaq
Medicare将覆盖价值2989.55美元的Illumina基因组癌症检测 - 股票泰坦
Medicare to cover $2,989.55 Illumina genomic cancer test - Stock Titan
Illumina公司TruSight™ Oncology Comprehensive获CMS报销批准，扩大精准肿瘤学可及性——PR Newswire报道
Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology - PR Newswire
Stifel因增长前景上调Illumina目标股价至155美元 - Investing.com
Stifel raises Illumina stock price target to $155 on growth outlook - Investing.com
GRAIL公司——Illumina剥离的圣杯（纳斯达克代码：GRAL）- Seeking Alpha
GRAIL Inc. - Illumina's Divested Holy Grail (NASDAQ:GRAL) - Seeking Alpha
Illumina Inc. (ILMN)股价目标获上调，分析师看好2026年潜在上涨空间——Insider Monkey
Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside - Insider Monkey
Illumina公司(ILMN)股价目标获上调，分析师看好2026年潜在上涨空间 - 雅虎财经
Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside - Yahoo Finance
Illumina：这条序列的下一步是什么？（纳斯达克股票代码：ILMN）- Seeking Alpha
Illumina: What Is Next In This Sequence? (NASDAQ:ILMN) - Seeking Alpha